Puma Biotechnology (PBYI) Accumulated Depreciation & Amortization (2017 - 2025)
Puma Biotechnology (PBYI) has disclosed Accumulated Depreciation & Amortization for 9 consecutive years, with $8.0 million as the latest value for Q1 2025.
- For the quarter ending Q1 2025, Accumulated Depreciation & Amortization rose 2.47% year-over-year to $8.0 million, compared with a TTM value of $8.0 million through Mar 2025, up 2.47%, and an annual FY2024 reading of $7.9 million, up 2.45% over the prior year.
- Accumulated Depreciation & Amortization was $8.0 million for Q1 2025 at Puma Biotechnology, up from $7.9 million in the prior quarter.
- Across five years, Accumulated Depreciation & Amortization topped out at $8.0 million in Q3 2024 and bottomed at $6.3 million in Q1 2021.
- Average Accumulated Depreciation & Amortization over 5 years is $7.4 million, with a median of $7.5 million recorded in 2022.
- The sharpest move saw Accumulated Depreciation & Amortization increased 11.54% in 2021, then rose 2.45% in 2024.
- Year by year, Accumulated Depreciation & Amortization stood at $6.9 million in 2021, then rose by 8.23% to $7.4 million in 2022, then increased by 3.42% to $7.7 million in 2023, then increased by 2.45% to $7.9 million in 2024, then rose by 1.3% to $8.0 million in 2025.
- Business Quant data shows Accumulated Depreciation & Amortization for PBYI at $8.0 million in Q1 2025, $7.9 million in Q4 2024, and $8.0 million in Q3 2024.